Partner with Us

Whether you're a researcher interested in collaborating or a patient or family member exploring potential nucleic acid–based therapies for a genetic condition, we encourage you to connect with us so we can learn more about your goals.

Complete this form to collaborate with us

The NATx Core supports gene-targeted therapies for rare diseases, pediatric conditions, and other areas where traditional drug development falls short, through the following services and expertise:

  • Design and refinement of therapeutic approaches, including antisense oligonucleotides and related nucleic acid modalities
  • Custom oligonucleotide synthesis and modifications for therapeutic discovery and mechanistic studies
  • Integrated design-to-validation workflows that guide projects from sequence design through synthesis and functional evaluation
  • Expert consultation and strategic guidance on advancing nucleic acid therapeutics from discovery-stage research toward translational and clinical development

Acknowledgement Statement

Below is suggested language for recognizing the center's contributions to your work: 

Research reported in this publication was supported by the University of Michigan Nucleic Acid Therapeutics (NATx) Core. The NATx Core is grateful for support from the U-M Life Sciences Institute and the U-M Biosciences Initiative. RRID:SCR_027422